News search

 Over one million European cancer patients suffer from side effects to chemotherapy

The jury acknowledged this CNIC researcher's contribution to understanding why obesity causes cardiometabolic diseases.

The €35,000 awarded by the foundation in each category is for research that deepens knowledge of the relationship between nutrition, food and health

The study, published in Nature in 2019, revealed relevant data about the involvement of the protein p38gamma in the development of the main type of primary liver cancer, which affects over a million people a year worldwide

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have designed a new strategy to potentiate immunotherapy, the treatment that has revolutionized cancer management

The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease

CNIC scientists have designed an animal model to study the development of liver cancer caused by bile acids

Published in Nature Communications, the study suggests that it may be possible to regulate the number and activity of these macrophages with drugs that modulate the nuclear receptor RXR